Cristiana C Garcia Selected Research

4-(2-amino-1-methyl-2-oxoethyl)phenyl trifluoromethanesulfonate

1/2017	CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection.
4/2009	Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristiana C Garcia Research Topics

Disease

11	Inflammation (Inflammations) 01/2018 - 04/2009
8	Infections 01/2018 - 11/2010
6	Lung Injury 01/2020 - 11/2010
6	Human Influenza (Influenza) 01/2018 - 04/2010
4	Pneumonia (Pneumonitis) 01/2017 - 04/2009
3	Fibrosis (Cirrhosis) 07/2011 - 04/2009
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2011 - 04/2009
2	Gout 01/2017 - 06/2015
2	Communicable Diseases (Infectious Diseases) 01/2016 - 04/2010
1	Virus Diseases (Viral Diseases) 01/2017
1	Colitis 03/2016
1	Pneumococcal Pneumonia 01/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2011
1	Idiopathic Pulmonary Fibrosis 07/2011

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2018 - 02/2011
4	ChemokinesIBA 01/2020 - 02/2011
3	Interleukin-10 (Interleukin 10)IBA 01/2018 - 03/2016
3	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 06/2015
3	Annexin A1IBA 01/2017 - 01/2016
3	indium-bleomycinIBA 07/2011 - 04/2009
3	Bleomycin (Blenoxane)FDA LinkGeneric 07/2011 - 04/2009
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018 - 02/2011
2	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2018
2	4-(2-amino-1-methyl-2-oxoethyl)phenyl trifluoromethanesulfonateIBA 01/2017 - 04/2009
2	Fibrinolysin FDA Link 01/2017 - 10/2014
2	PlasminogenIBA 01/2017 - 10/2014
2	Uric Acid (Urate)IBA 01/2017 - 06/2015
2	RolipramIBA 01/2016 - 05/2010
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 07/2011
2	CaspasesIBA 05/2015 - 05/2010
2	CollagenIBA 02/2011 - 04/2009
1	Phosphotransferases (Kinase)IBA 01/2018
1	Interferon LambdaIBA 01/2018
1	Neuraminidase (Sialidase)IBA 01/2018
1	LigandsIBA 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Dietary Fiber FDA Link 01/2017
1	Volatile Fatty AcidsIBA 01/2017
1	Drinking WaterIBA 03/2016
1	Sulfalene (Longum)IBA 03/2016
1	Dextrans (Dextran)FDA Link 03/2016
1	SolutionsIBA 03/2016
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2016
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 03/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	InflammasomesIBA 06/2015
1	GlucocorticoidsIBA 05/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2015
1	Biological ProductsIBA 10/2014
1	FibrinIBA 10/2014
1	Complement C5 (Complement 5)IBA 01/2013
1	Immunoglobulin M (IgM)IBA 01/2013
1	Complement System Proteins (Complement)IBA 01/2013
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2012
1	EsterasesIBA 01/2012
1	Monocyte Chemoattractant ProteinsIBA 07/2011
1	Carrier Proteins (Binding Protein)IBA 07/2011
1	CC ChemokinesIBA 07/2011
1	Therapeutic UsesIBA 07/2011
1	Platelet Activating FactorIBA 11/2010
1	EnzymesIBA 11/2010
1	1-alkylglycerophosphocholine acetyltransferaseIBA 11/2010
1	platelet activating factor receptorIBA 11/2010
1	Phosphodiesterase 4 InhibitorsIBA 05/2010
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 05/2010
1	NF-kappa B (NF-kB)IBA 05/2010
1	VaccinesIBA 04/2010
1	Surface Antigens (Surface Antigen)IBA 04/2010
1	Chemokine ReceptorsIBA 04/2009
1	Interleukin-13IBA 04/2009

Therapy/Procedure

2	Therapeutics 01/2016 - 11/2010
1	Immunomodulation 03/2016
1	Oral Administration 03/2016
1	Transplantation 03/2016
1	Intraperitoneal Injections 01/2013